Phosphorylation of enabled by the Drosophila abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of enabled

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 152-160

  Comer, Allen R ^a   Ahern Djamali, Shawn M ^a   Juang, Jyh Lyh ^a   Jackson, P David ^b   Hoffmann, F M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL PROTEIN ENABLED; ONCOPROTEIN; ONCOPROTEIN ABL; UNCLASSIFIED DRUG;

ARTICLE; DROSOPHILA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALIA; ENA; HEXAPODA; MAMMALIA; MURINAE;

EID: 0031972950     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.1.152     Document Type: Article

References (62)

1. Ahern-Djamali, S. M., A. R. Comer, P. Hua, C. Bachmann, M. C. Beckerle, U. Walter, and F. M. Hoffmann. Submitted for publication.
2. Andoniou, C. E., C. B. Thien, and W. Y. Langdon. 1996. The two major sites of Cbl phosphorylation in Abl-transformed cells select the Crkl SH2 domain. Oncogene 12:1981-1989.
3. Ausubel, F. M., R. Brent, R. Kingston, D. Moore, J. G. Seidman, J. A. Smith, and K. Strahl (ed.). 1987. Current protocols in molecular biology. Wiley Interscience, New York, N.Y.
4. Bar-Sagi, D., D. Rotin, A. Batzer, V. Mandiyan, and J. Schlessinger. 1993. SH3 domains direct cellular localization of signaling molecules. Cell 74:83-91.
5. Baskaran, R., L. D. Wood, L. L. Whitaker, C. E. Canman, S. E. Morgan, Y. Xu, C. Barlow, D. Baltimore, A. Wynshaw-Boris, M. B. Kastan, and J. Y. J. Wang. 1997. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387:516-519.
6. Bork, P., and B. Margolis. 1995. A phosphotyrosine interaction domain. Cell 80:693-694.
7. Boyle, W. J., P. Van Der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
8. Brand, A. H., and N. Perrimon. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415.
9. Broome, M. A., and T. Hunter. 1997. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding. Oncogene 14:17-34.
10. Carpino, N., D. Wisniewski, A. Strife, D. Marshak, R. Kobayashi, B. Stillman, and B. Clarkson. 1997. p62(dok): a constitutively tyrosine-phosphorylated. GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204.
11. Chakraborty, T., F. Ebel, E. Domann, K. Niebuhr, B. Gerstel, S. Pistor, C. Temm-Grove, B. Jockusch, M. Reinhard, U. Walter, and J. Wehland. 1995. A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Lisieria ivanovii to the actin-based cytoskeleton of mammalian cells. EMBO J. 14:1314-1321.
12. Comer, A. R., F. B. Gertler, and F. M. Hoffmann. Unpublished data.
13. Dai, Z., and A. M. Pendergast. 1995. Abi-2 a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9:2569-2582.
14. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.
15. Duyster, J., R. Baskaran, and J. Y. J. Wang. 1995. Src homology 2 domain as a specificity determinant in the c-Abl mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc. Natl. Acad. Sci. USA 92:1555-1559.
16. Elkins, T., K. Zinn, L. McAllister, F. M. Hoffmann, and C. S. Goodman. 1990. Genetic analysis of a Drosophila neural cell adhesion molecule: interaction of fasciclin I and Abelson tyrosine kinase mutations. Cell 60:565-575.
17. Fainstein, E., C. Marcelle, A. Rosner, E. Canaani, R. P. Gale, O. Dreazen, S. D. Smith, and C. M. Croce. 1987. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386-388.
18. Feller, S. M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13:2341-2351.
19. Gertler, F., K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano. 1996. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87:227-239.
20. Gertler, F. B., R. L. Bennett, M. J. Clark, and F. M. Hoffmann. 1989. Drosophila Abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58:103-113.
21. Gertler, F. B., A. R. Comer, J.-L. Juang, S. M. Ahern, M. J. Clark, E. C. Liebl, and F. M. Hoffmann. 1995. Enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3-binding properties. Genes Dev. 9:521-533.
22. Gertler, F. B., J. S. Doctor, and F. M. Hoffmann. 1990. Genetic suppression of mutations in the Drosophila Abl proto-oncogene homolog. Science 248: 857-860.
23. Goga, A., X. Liu, T. M. Hambuch, K. Senechal, E. Major, A. J. Berk, O. N. Witte, and C. L. Sawyers. 1995. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11:791-799.
24. Gotoh, A., K. Miyazawa, K. Ohyashiki, T. Tauchi, H. S. Boswell, H. E. Broxmeyer, and K. Toyama. 1995. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Exp. Hematol. 23:1153-1159.
25. Gregory, R. J., K. L. Kammermeyer, W. S. de Vincent, and S. G. Wadsworth. 1987. Primary sequence and developmental expression of a novel Drosophila melanogaster src gene. Mol. Cell. Biol. 7:2119-2127.
26. Henkemeyer, M., S. R. West, F. B. Gertler, and F. M. Hoffmann. 1990. A novel tyrosine kinase-independent function of Drosophila Abl correlates with proper subcellular localization. Cell 63:949-960.
27. Holland, G. D., M. J. Henkemeyer, D. A. Kaehler, F. M. Hoffmann, and R. Risser. 1990. Conservation of function of Drosophila melanogaster Abl and murine v-Abl proteins in transformation of mammalian cells. J. Virol. 64: 2226-2235.
28. Horstrup, K., B. Jablonka, P. Honig-Liedl, M. Just, K. Kochsiek, and U. Walter. 1994. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur. J. Biochem. 225:21-27.
29. Karas, M., D. Bachmann, U. Bahr, and F. Hillenkamp. 1987. Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. Ion Process. 78:53-68.
30. Karas, M., and F. Hillenkamp. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Biochem. 60:2299-2301.
31. Kavanaugh, W. M., and L. T. Williams. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862-1865.
32. Lewis, J., R. Baskaran, S. Taagepera, M. Schwartz, and J. Wang. 1996. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA 93:15174-15179.
33. Lim, W. A., F. M. Richards, and R. O. Fox. 1994. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372:375-379.
34. Lowell, C. A., P. Soriano, and H. E. Varmus. 1994. Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. Genes Dev. 8:387-398.
35. Machesky, L. M. 1997. Cell motility: complex dynamics at the leading edge. Curr. Biol. 7:R164-R167.
36. Mayer, B. J., H. Hirai, and R. Sakai. 1995. Evidence that SH2 domains promote processive phosphorylation by protein tyrosine kinases. Curr. Biol. 5:296-305.
37. McWhirter, J. R., and J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-Abl by Bcr sequences in Bcr/Abl fusion proteins. Mol. Cell. Biol. 11:1553-1565.
38. McWhirter, J. R., and J. Y. J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533-1546.
39. Perrimon, N. Personal communication.
40. Reinhard, M., K. Giehl, K. Abel, C. Haffner, T. Jarchau, V. Hoppe, B. Jockusch, and U. Walter. 1995. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J. 14:1583-1589.
41. Reinhard, M., M. Halbrugge, U. Scheer, C. Wiegand, B. Jockusch, and U. Walter. 1992. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J. 11:2063-2070.
42. Ren, R., Z.-S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783-795.
43. Rubin, G. M., and A. C. Spradling. 1982. Genetic transformation of Drosophila with transposable element vectors. Science 218:348-353.
44. Salgia, R., B. Brunkhorst, E. Pisick, J. L. Li, S. H. Lo, L. B. Chen, and J. D. Griffin. 1995. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Oncogene 11:1149-1155.
45. Sawyers, C. L., J. McLaughlin, A. Goga, M. Havlik, and O. Witte. 1994. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77:121-131.
46. Shafman, T., K. K. Khanna, P. Kedar, K. Spring, S. Kozlov, T. Yen, K. Hobson, M. Gatei, N. Zhang, D. Watters, M. Egerton, Y. Shiloh, S. Kharbanda, D. Kufe, and M. F. Lavin. 1997. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387:520-523.
47. Shi, Y., A. Kimona, and S. P. Goff. 1995. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes Dev. 9:2583-2597.
48. Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myclogenous leukemia. Nature 315: 550-554.
49. Simon, M. A., B. Drees, T. Kornberg, and J. M. Bishop. 1985. The nucleotide sequence and the tissue-specific expression of Drosophila c-src. Cell 42:831-840.
50. Songyang, Z., K. L. Carraway III, M. J. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, M. J. Lorenzo, B. A. J. Ponder, B. J. Mayer, and L. C. Cantley. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539.
51. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
52. Stein, P. L., H. Vogel, and P. Soriano. 1994. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8:1999-2007.
53. Takahashi, F., S. Endo, T. Kojima, and K. Saigo. 1996. Regulation of cell-cell contacts in developing Drosophila eyes by Dsrc41, a new, close relative of vertebrate c-src. Genes Dev. 10:1645-1656.
54. Tanaka, M., R. Gupta, and B. J. Mayer. 1995. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 15:6829-6837.
55. Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
56. Van Etten, R. A., P. K. Jackson, D. Baltimore, M. C. Sanders, P. T. Matsudaira, and P. A. Janmey. 1994. The COOH terminus of the c-Abl tyrosine kinase contains distinct F-and G-actin binding domains with bundling activity. J. Cell Biol. 124:325-340.
57. Verfaillie, C. M., J. B. McMarthy, and P. B. McGlave. 1992. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J. Clin. Invest. 90:1232-1241.
58. Walter, U., M. Eigenthaler, J. Geiger, and M. Reinhard. 1993. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv. Exp. Med. Biol. 344:237-249.
59. Wang, J. Y. J. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35-43.
60. Wetzler, M., M. Talpaz, R. A. Van Etten, C. Hirsch-Ginsberg, M. Beran, and R. Kurzrock. 1994. Suhcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 92:1925-1939.
61. Yamanashi, Y., and D. Baltimore. 1997. Identification of the Abl-and ras-GAP-associated 62 kDa protein as a docking protein. Dok. Cell 88:205-211.
62. Yu, H., J. K. Chen, S. Feng, D. C. Dalgarno, A. W. Brauer, and S. L. Schreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933-945.